Differential Clinical Significance of FENO200 and CANO in Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Asthma-COPD Overlap (ACO)
In asthma, COPD and ACO, FENO<sub>200</sub> has demonstrated a robust correlation with CANO. Elevated FENO<sub>200</sub> levels are predominantly indicative of pulmonary function impairment in asthma and COPD, whereas elevated CANO levels are mainly correlated with pulmonary function impairment in COPD and ACO. Compared with FENO<sub>200</sub> and CANO, FENO<sub>50</sub> may have a better discriminatory ability in distinguishing asthma, COPD and ACO.
Authors
- Lichang Chen (ORCID: https://orcid.org/0000-0001-7096-0494)
- Guansheng Zeng (ORCID: https://orcid.org/0000-0002-9248-0528)
- Huapeng Yu (ORCID: https://orcid.org/0000-0001-6033-0907)
- Xu Jian (ORCID: https://orcid.org/0000-0002-2451-2401)
- Cuilan Wang (ORCID: https://orcid.org/0000-0001-7948-0649)
- Huadong Zeng (ORCID: https://orcid.org/0000-0002-8425-2410)
Institutions
- Zhujiang Hospital (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Journal of Asthma and Allergy
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/jaa.s486324
- Citations
- 6
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 2.51
Funders
- Southern Medical University
- Shenzhen Hospital, Southern Medical University